Covered recipient · General Payments record
JORGE G DARCOURT
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$114,349.45
- Reported across 211 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $43,200.00 | 8 |
| Consulting Fee | $7,600.00 | 4 |
| Travel and Lodging | $6,738.19 | 16 |
| Food and Beverage | $1,986.80 | 54 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $46,923.09 | 40 |
| Eli Lilly and Company | $6,800.00 | 3 |
| Lilly USA, LLC | $4,800.00 | 2 |
| GENZYME CORPORATION | $143.46 | 4 |
| Celgene Corporation | $124.01 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $105.51 | 5 |
| SECURA BIO, INC. | $87.86 | 1 |
| PFIZER INC. | $70.79 | 3 |
| SOBI, INC | $69.20 | 2 |
| Incyte Corporation | $44.57 | 2 |
| Tempus AI, Inc | $43.52 | 1 |
| Astellas Pharma US Inc | $38.89 | 2 |
| SpringWorks Therapeutics, Inc. | $32.69 | 2 |
| TerSera Therapeutics LLC | $32.57 | 1 |
| EISAI INC. | $29.44 | 1 |
| Daiichi Sankyo Inc. | $28.96 | 1 |
| Stemline Therapeutics Inc. | $23.62 | 1 |
| E.R. Squibb & Sons, L.L.C. | $23.47 | 1 |
| BeiGene USA, Inc. | $23.18 | 1 |
| Genentech USA, Inc. | $22.62 | 1 |
| Acerta Pharma LLC | $21.26 | 1 |
| ABBVIE INC. | $20.13 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $16.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (82)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.